These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
73 related articles for article (PubMed ID: 6947669)
1. The correlation of cytologic grade and steroid receptor content in effusions of metastatic breast carcinoma. Mossler JA; McCarty KS; Johnston WW Acta Cytol; 1981; 25(6):653-8. PubMed ID: 6947669 [TBL] [Abstract][Full Text] [Related]
2. Estrogen and progesterone receptors status in Thai female breast cancer patients: an analysis of 399 cases at King Chulalongkorn Memorial Hospital. Lertsanguansinchai P; Chottetanaprasith T; Chatamra K; Sampatanukul P; Wannakrairot P; Rojpornpradit P; Shotelersuk K; Lertbutsayanukul C; Boonjunwetwat D; Vajragupta L J Med Assoc Thai; 2002 Jun; 85 Suppl 1():S193-202. PubMed ID: 12188412 [TBL] [Abstract][Full Text] [Related]
3. Biochemical correlates of morphologic differentiation in human breast cancer. Silva JS; Cox CE; Wells SA; Paull D; Dilley WG; McCarty KS; Fetter BF; Glaubitz LC; McCarty KS Surgery; 1982 Sep; 92(3):443-9. PubMed ID: 7202259 [TBL] [Abstract][Full Text] [Related]
4. Correlation of estrogen and progesterone receptors with histologic differentiation in endometrial adenocarcinoma. McCarty KS; Barton TK; Fetter BF; Creasman WT; McCarty KS Am J Pathol; 1979 Jul; 96(1):171-83. PubMed ID: 464018 [TBL] [Abstract][Full Text] [Related]
5. Impact of metastatic estrogen receptor and progesterone receptor status on survival. Lower EE; Glass EL; Bradley DA; Blau R; Heffelfinger S Breast Cancer Res Treat; 2005 Mar; 90(1):65-70. PubMed ID: 15770528 [TBL] [Abstract][Full Text] [Related]
6. Angiogenesis and ER/PR status in primary breast cancer patients: an analysis of 158 needle core biopsies. Vameşu S Rom J Morphol Embryol; 2007; 48(1):25-31. PubMed ID: 17502947 [TBL] [Abstract][Full Text] [Related]
8. Correlation of mean nuclear area with estrogen receptor content in aspiration cytology of breast carcinoma. Mossler JA; McCarty KS; Woodard BH; Mitchener LM; Johnston WW Acta Cytol; 1982; 26(4):417-21. PubMed ID: 6957091 [TBL] [Abstract][Full Text] [Related]
9. Progesterone receptor loss correlates with human epidermal growth factor receptor 2 overexpression in estrogen receptor-positive breast cancer. Kim HJ; Cui X; Hilsenbeck SG; Lee AV Clin Cancer Res; 2006 Feb; 12(3 Pt 2):1013s-1018s. PubMed ID: 16467118 [TBL] [Abstract][Full Text] [Related]
10. Changes in estrogen receptor, progesterone receptor and Her-2/neu status with time: discordance rates between primary and metastatic breast cancer. Broom RJ; Tang PA; Simmons C; Bordeleau L; Mulligan AM; O'Malley FP; Miller N; Andrulis IL; Brenner DM; Clemons MJ Anticancer Res; 2009 May; 29(5):1557-62. PubMed ID: 19443366 [TBL] [Abstract][Full Text] [Related]
11. Comparison of triple-negative and estrogen receptor-positive/progesterone receptor-positive/HER2-negative breast carcinoma using quantitative fluorine-18 fluorodeoxyglucose/positron emission tomography imaging parameters: a potentially useful method for disease characterization. Basu S; Chen W; Tchou J; Mavi A; Cermik T; Czerniecki B; Schnall M; Alavi A Cancer; 2008 Mar; 112(5):995-1000. PubMed ID: 18098228 [TBL] [Abstract][Full Text] [Related]
12. [Discordance of estrogen receptor (ER), progestin receptor (PR), and HER-2 receptor statuses between primary and metastatic focuses of breast cancer]. Wang B; Guan ZZ; Liu DG; Lin TY; Zhang L; Xia ZJ; Teng XY Ai Zheng; 2004 Dec; 23(12):1710-3. PubMed ID: 15601567 [TBL] [Abstract][Full Text] [Related]
13. Correlation of her-2/neu gene amplification with other prognostic and predictive factors in female breast carcinoma. Ariga R; Zarif A; Korasick J; Reddy V; Siziopikou K; Gattuso P Breast J; 2005; 11(4):278-80. PubMed ID: 15982396 [TBL] [Abstract][Full Text] [Related]
14. Morphological profile and association of HER-2/neu with prognostic markers in breast carcinoma in Northern Pakistan. Sharif MA; Mamoon N; Mushtaq S; Khadim MT J Coll Physicians Surg Pak; 2009 Feb; 19(2):99-103. PubMed ID: 19208313 [TBL] [Abstract][Full Text] [Related]
15. Prostate-specific antigen value as a marker in breast cancer. Narita D; Cimpean AM; Anghel A; Raica M Neoplasma; 2006; 53(2):161-7. PubMed ID: 16575473 [TBL] [Abstract][Full Text] [Related]
16. Alterations of estrogen receptors, progesterone receptors and c-erbB2 oncogene protein expression in ductal carcinomas of the breast. Hussein MR; Abd-Elwahed SR; Abdulwahed AR Cell Biol Int; 2008 Jun; 32(6):698-707. PubMed ID: 18296077 [TBL] [Abstract][Full Text] [Related]
17. Breast cancer: steroid receptors and other prognostic indicators. Fatima S; Faridi N; Gill S J Coll Physicians Surg Pak; 2005 Apr; 15(4):230-3. PubMed ID: 15857597 [TBL] [Abstract][Full Text] [Related]
18. The stability of estrogen and progesterone receptor expression on breast carcinoma cells stored as PreservCyt suspensions and as ThinPrep slides. Tabbara SO; Sidawy MK; Frost AR; Brosky KR; Coles V; Hecht S; Radcliffe G; Sherman ME Cancer; 1998 Dec; 84(6):355-60. PubMed ID: 9915137 [TBL] [Abstract][Full Text] [Related]
19. Nuclear areas in breast cancer: relationship with estrogen and progesterone receptor expression. Maiorana A; Cavallari V; Bagni A; Ussia F; Maiorana MC; Fano RA Anal Cell Pathol; 1996 Aug; 11(3):199-209. PubMed ID: 8888955 [TBL] [Abstract][Full Text] [Related]
20. Immunohistochemical expression of hormone receptors in invasive breast carcinoma: correlation of results of H-score with pathological parameters. Thike AA; Chng MJ; Fook-Chong S; Tan PH Pathology; 2001 Feb; 33(1):21-5. PubMed ID: 11280603 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]